CIK 0001555279
- Non-accelerated filer
- Smaller reporting company
908 Devices Inc.
Sign in to watch- Ticker
- MASS
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454524096
- Phone
- +1 978-729-4478
- Business address
- 44 THIRD AVENUE, BURLINGTON, MA, 01803
- 4 Open-market buy President and CEO bought 10,000 shares at $5.83 ($58,300)
- 4 Open-market buy President and CEO bought 10,000 shares at $5.72 ($57,200)
- 4 Open-market buy President and CEO bought 10,000 shares at $5.60 ($56,000)
- 4 Option exercise President and CEO acquired 47,000 shares (option exercise)
- 4 Option exercise Chief Product Officer acquired 3,600 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 8,437 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 2,057 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 508 shares (option exercise)
- 4 Option exercise Director acquired 508 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 15,409 shares at an average $7.06 ($108,765)
- 4 Open-market sale Chief Legal & Admin Officer sold 5,232 shares at an average $6.99 ($36,559)
- 4 Open-market sale President and CEO sold 9,071 shares at an average $7.00 ($63,461)
- 4 Open-market sale Chief Product Officer sold 3,957 shares at an average $7.01 ($27,730)
- 4 Open-market sale Chief Financial Officer sold 6,000 shares at $12.08 ($72,480)
- 4 Open-market sale Chief Financial Officer sold 5,580 shares at $9.08 ($50,666)
- 4 Open-market sale Chief Product Officer sold 20,000 shares at an average $9.10 ($182,000)
Page 6 of 14 · 280 filings